	流动负债		日
Acadia Pharmaceuticals	USD 277.11M	79.47M	2025-12
Adma Biologics	USD 69.54M	13.05M	2025-12
ALKERMES	USD 599.5M	56.06M	2026-03
Alterity Therapeutics Limited	AUD 1.73M	2.77M	2025-12
AstraZeneca	USD 32.57B	1.95B	2026-03
BioCryst Pharmaceuticals	USD 196.07M	5.83M	2025-12
Bristol-Myers Squibb	USD 19.16B	4.26B	2026-03
Cipla	INR 62.97B	8.13B	2025-09
Clal Biotechnology	ILS 6.66M	3.75M	2023-12
Compugen	USD 22.57M	2.29M	2025-12
CSL	USD 4.61B	207M	2025-12
Eli Lilly	USD 36.63B	1.41B	2026-03
Esperion Therapeutics	USD 300.81M	58.22M	2025-12
GlaxoSmithKline	GBP 22.43B	1.04B	2026-03
Grifols	EUR 2.37B	156.97M	2025-12
Halozyme Therapeutics	USD 177.09M	660.14M	2025-12
Ionis Pharmaceuticals	USD 717M	66M	2026-03
J&J	USD 57.72B	3.59B	2026-03
Merck	USD 26.94B	1.38B	2026-03
Minerva Neurosciences	USD 2.29M	381K	2025-12
Neurocrine Biosciences	USD 831.7M	88.3M	2026-03
Novartis	USD 31.37B	4.1B	2026-03
Novavax	USD 459.95M	30.08M	2025-12
Pfizer	USD 34.35B	2.64B	2026-03
Roche Holding	CHF 28B	421M	2025-12
Sanofi	EUR 30.01B	1.66B	2026-03
Takeda	JPY 2.61T	470.53B	2025-12
Vanda Pharmaceuticals	USD 145.16M	27.29M	2025-12